GlassScriptPhysician profile
Michelle W Murphy
NPI 1710060157
$2,621.34
in general payments reported to CMS, 2019-2025
24 companies · $521 in 2025
The $521 reported for 2025 was more than what 76% of Gynecology providers received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $33.38 · 2021: $92.85 · 2022: $447 · 2023: $699 · 2024: $611 · 2025: $521.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,745 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.07 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $668.19 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $350.73 | 2022-2025 | Slynd |
| Abbvie INC. | $248.89 | 2019-2022 | |
| Hologic Sales and Service, LLC | $233.91 | 2019-2023 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $188.56 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $153.12 | 2023-2025 | Myfembree |
| Pfizer INC. | $142.77 | 2021-2023 | |
| Novo Nordisk INC | $133.48 | 2022-2024 | Wegovy |
| Gynesonics, INC. | $110.96 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $76.05 | 2025 | Femlyv, Intrarosa |
| Medtronic, INC. | $73.82 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $29.74 | 2019-2025 | |
| Myovant Sciences INC. | $26.60 | 2022 | |
| Avanos Medical | $22.16 | 2019 | |
| Biogen, INC. | $19.87 | 2025 | Zurzuvae |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien LP | $19.39 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.13 | 2023 | |
| Therapeuticsmd, INC. | $17.15 | 2022 | |
| Ethicon US, LLC | $16.84 | 2019 | |
| Mylan Pharmaceuticals INC. | $15.96 | 2022 | |
| Organon LLC | $15.01 | 2024 | |
| Convatec INC. | $14.53 | 2019 | |
| Avion Pharmaceuticals | $13.53 | 2022 | |
| Lupin INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.